Carmel Capital Partners, LLC Laboratory Corp Of America Holdings Transaction History

Carmel Capital Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$209.01 - $232.56 $14,630 - $16,279	70 Added 1.38%	5,152 $1.13 Million
Q4 2023 Jan 31, 2024	BUY	$197.69 - $227.29 $7,314 - $8,409	37 Added 0.73%	5,082 $1.16 Million
Q3 2023 Oct 27, 2023	SELL	$201.05 - $221.7 $103,942 - $114,618	-517 Reduced 9.3%	5,045 $1.01 Million
Q2 2023 Jul 27, 2023	BUY	$211.93 - $241.33 $117,621 - $133,938	555 Added 11.08%	5,562 $1.34 Million
Q1 2023 Apr 19, 2023	BUY	$213.32 - $257.83 $43,303 - $52,339	203 Added 4.23%	5,007 $1.15 Million
Q4 2022 Jan 17, 2023	SELL	$203.72 - $248.97 $38,095 - $46,557	-187 Reduced 3.75%	4,804 $0
Q3 2022 Oct 14, 2022	SELL	$204.81 - $262.19 $144,595 - $185,106	-706 Reduced 12.39%	4,991 $1.02 Million
Q2 2022 Jul 11, 2022	BUY	$213.86 - $277.87 $91,745 - $119,206	429 Added 8.14%	5,697 $1.34 Million
Q1 2022 Apr 18, 2022	BUY	$259.82 - $298.18 $21,045 - $24,152	81 Added 1.56%	5,268 $1.39 Million
Q4 2021 Jan 31, 2022	BUY	$271.6 - $314.21 $1.41 Million - $1.63 Million	5,187 New	5,187 $1.63 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Carmel Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Carmel Capital Partners, LLC with notifications on news.